[go: up one dir, main page]

GT200600152A - Derivados de tetrahidronaftalina, procedimiento para su preparación y su uso como antiinflamatorios - Google Patents

Derivados de tetrahidronaftalina, procedimiento para su preparación y su uso como antiinflamatorios

Info

Publication number
GT200600152A
GT200600152A GT200600152A GT200600152A GT200600152A GT 200600152 A GT200600152 A GT 200600152A GT 200600152 A GT200600152 A GT 200600152A GT 200600152 A GT200600152 A GT 200600152A GT 200600152 A GT200600152 A GT 200600152A
Authority
GT
Guatemala
Prior art keywords
tetrahydronaftaline
inflammatory
preparation
derivatives
procedure
Prior art date
Application number
GT200600152A
Other languages
English (en)
Inventor
Anne Mengel
Konrad Krolikiewicz
Stefan Baurle
Heike Schacke
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200600152A publication Critical patent/GT200600152A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/42—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C215/44—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having amino groups or hydroxy groups bound to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton bound to carbon atoms of the same ring or condensed ring system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38—Nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Rheumatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

LA INVENCIÓN SE RELACIONA CON VARIOS DERIVADOS DE TETRAHIDRONAFTALINA SUSTITUIDOS DE LA FÓRMULA (I), CON PROCEDIMIENTOS PARA SU PREPARACIÓN Y CON SU USO COMO ANTIINFLAMATORIOS.
GT200600152A 2005-04-14 2006-04-17 Derivados de tetrahidronaftalina, procedimiento para su preparación y su uso como antiinflamatorios GT200600152A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005017316A DE102005017316A1 (de) 2005-04-14 2005-04-14 Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer

Publications (1)

Publication Number Publication Date
GT200600152A true GT200600152A (es) 2007-03-19

Family

ID=36889239

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200600152A GT200600152A (es) 2005-04-14 2006-04-17 Derivados de tetrahidronaftalina, procedimiento para su preparación y su uso como antiinflamatorios

Country Status (8)

Country Link
AR (1) AR053582A1 (es)
DE (1) DE102005017316A1 (es)
DO (1) DOP2006000089A (es)
GT (1) GT200600152A (es)
PE (1) PE20061360A1 (es)
TW (1) TW200716565A (es)
UY (1) UY29482A1 (es)
WO (1) WO2006108713A2 (es)

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63220242A (ja) * 1987-03-10 1988-09-13 Fuji Photo Film Co Ltd フオトレジスト組成物
JPH02501737A (ja) * 1987-05-15 1990-06-14 シェリング・コーポレーション アリール置換ナフタリン，ベンゾオキセピン，ベンズアゼピン，ベンゾシクロヘプテン誘導体
HU204828B (en) * 1987-07-16 1992-02-28 Byk Gulden Lomberg Chem Fab Process for producing new diazole derivatives and pharmaceutical compositions comprising such compounds
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases
JPH0641038A (ja) * 1992-07-17 1994-02-15 Mitsubishi Kasei Corp カルボン酸誘導体
US5489584A (en) * 1994-12-29 1996-02-06 Allergan, Inc. Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity
CA2297906A1 (en) * 1997-07-22 1999-02-04 Bret Eugene Huff Pharmaceutical compounds
GB9716244D0 (en) * 1997-07-31 1997-10-08 Electrophoretics International Pharmaceutical compounds
US6333337B1 (en) * 1998-01-27 2001-12-25 Icagen, Inc. Potassium channel inhibitors
US6013830A (en) * 1998-03-30 2000-01-11 Sepracor Inc. Asymmetric grignard synthesis with cyclic 1,2 aminoalcohols
AU5682299A (en) * 1998-08-21 2000-03-14 Scripps Research Institute, The Catalytic asymmetric aminohydroxylation with amino-substituted heterocycles
JP2000256255A (ja) * 1999-03-10 2000-09-19 Kuraray Co Ltd （±）−トランス−ペルメトリン酸の光学分割法
SE9903930D0 (sv) * 1999-10-29 1999-10-29 Astra Pharma Inc Novel compounds and a novel process for their preparation
ES2193839B1 (es) * 2001-06-22 2005-02-16 Almirall Prodesfarma, S.A. Nuevos derivados de 6-fenildihidropirrolpirimidindiona.
JP4409290B2 (ja) * 2001-09-21 2010-02-03 イーライ リリー アンド カンパニー ムスカリン性アゴニスト
UY27450A1 (es) * 2001-09-24 2003-04-30 Bayer Corp Preparación y uso de derivados de imidazol para el tratamiento de la obesidad
ATE447561T1 (de) * 2001-11-21 2009-11-15 Pharmacia & Upjohn Co Llc Substituierte aryl 1,4-pyrazin derivate
US6875866B2 (en) * 2002-02-21 2005-04-05 Schering Corporation Process for synthesis of D1 receptor antagonists
DE50312532D1 (de) * 2002-08-26 2010-04-29 Merck Patent Gmbh CYCLOPENTA iB NAPHTHALINDERIVATE
WO2005021682A1 (de) * 2003-08-22 2005-03-10 Merck Patent Gmbh Cyclopenta[a]naphthalinderivate
CN1239441C (zh) * 2003-09-12 2006-02-01 中国科学院上海有机化学研究所 利用固载化的双辛可尼类生物碱配体催化不对称羟胺化和双羟化反应的方法

Also Published As

Publication number Publication date
WO2006108713A2 (de) 2006-10-19
DOP2006000089A (es) 2006-11-15
TW200716565A (en) 2007-05-01
AR053582A1 (es) 2007-05-09
WO2006108713A3 (de) 2006-12-14
PE20061360A1 (es) 2007-01-26
DE102005017316A1 (de) 2006-10-19
UY29482A1 (es) 2006-10-31

Similar Documents

Publication Publication Date Title
CO6491116A2 (es) Derivados de 5-fluoropirimidinona
UY30057A1 (es) Pirimidinas sustituidas con sulfoximinas, procesos para su producción y uso de las mismas como fármacos
HN2012000263A (es) Derivados n1-sulfonil-5-fluoropirimidinona
CO6321282A2 (es) Derivados de piperidinilindol como inhibidores de aldosterona sintasa
DOP2011000171A (es) Compuestos organico
ECSP077259A (es) Derivados de pirimidina
BRPI0812222A2 (pt) Compostos ciclobutenodiona substituídos anti-inflamatórios.
GT201000037A (es) Depsipéptidos cíclicos
ECSP12011653A (es) Derivados de n1-acil-5-fluoropirimidinona
ECSP088740A (es) Derivados de tetrahidronaftalina, procedimientos para prepararlos y su uso como antiinflamatorios
ECSP077306A (es) Derivados de alquiliden-tetrahidronaftaleno, procedimiento para su preparación y su uso como antiinflamatorios
UY30801A1 (es) Compuestos calciliticos
UY29434A1 (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como inhibidores de la inflamacinn
GT200600153A (es) Derivados de tetrahidronaftalina, procedimientos para su preparación y su uso como antiinflamatorios.
CO6501125A2 (es) Nuevos derivados (heterociclico-tetrahidro-piridin)-(piperazinil)-1- alcanona y (heterociclo-dhidro-pirrolidin)-(piperazinil)-1-alcanona y su utilización como inhibidores de p75
GT200600152A (es) Derivados de tetrahidronaftalina, procedimiento para su preparación y su uso como antiinflamatorios
GT200600124A (es) Derivado de 5h-benzociclohepteno, procedimiento para su preparación y su uso como antiinflamatorios
CO6561812A2 (es) Derivados de 2-aldoximino-5-fluoropirimidina
DK1893597T3 (da) AMPA-receptorpotentiatorer
DOP2006000064A (es) Derivados de tetrahidronaftalina, procedimientos para su preparacion y su uso como inhibidores de la inflamacion
UY28907A1 (es) Derivados de cromanol, un procedimiento para su preparación y su uso como inhibidores de la inflamación.
UY29309A1 (es) Aminoalcoholes tricíclicos, procedimientos para su preparación y su uso como inhibidores de inflamación
SV2008001926A (es) Derivados de tetrahidronaftaleno, procedimiento para su preparacion y su uso como antiinflamatorio. ref. p-sv-77.295/cd
CU23569A3 (es) Derivados 1-amino-2-oxi sustituidos del tetrahidronaftaleno, procedimiento para su producción y su uso como antinflamatorio
DOP2005000180A (es) Inhibidores bace